Molecular targeted treatment and radiation therapy for rectal cancer.
about
Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsetsThe current state of targeted agents in rectal cancer.Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinomaLapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trialNuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.Omega-3 fatty acid supplementation in cancer therapy : does eicosapentanoic acid influence the radiosensitivity of tumor cells?Overexpression of caveolin-1 in lymphoblastoid TK6 cells enhances proliferation after irradiation with clinically relevant doses.Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancer.Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer.Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer : Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trial.Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit?Erlotinib-induced rash spares previously irradiated skin.Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].
P2860
Q33816412-66F11C80-3F32-43DB-A795-475821A153EAQ33834316-CCA42640-144F-4BBE-8448-E4DE3CD6EECFQ33997798-E4F1B6C7-9D46-403B-AD7C-F2E40A6C026AQ35083126-96B60CDA-A913-442D-9DE4-8F4E27C017E7Q35996651-4D3ADBF4-E8E7-4C1D-931B-ABF1E415CC9BQ36368072-6F0DC08F-3038-49A0-BF16-FCA9734BF2BCQ37272825-E907D7DF-B485-4CA8-A676-BB1E12A73C4CQ37676970-C54F9AE6-323A-4CA6-9E4C-431137A184FBQ37743143-38741E71-9910-4426-9AA0-FD5E6BE42828Q37817000-9A7A2E3A-97F8-49BC-8E3D-C0938D63F73AQ38064748-01119347-5B89-4829-B927-69523D568B55Q39602064-3AE490B0-EFB7-42EE-B6F4-205573629AA8Q39602655-14EF9DD4-3706-4391-906F-53740C509F81Q39744649-EDBD82FD-EDF9-40AD-B012-00036CB40FB1Q39793772-6C90DFB3-A1FF-4629-B110-BB35D74C03FAQ46420172-533D55DA-FA02-41BA-95BF-B53965034A12Q50062237-5BF194A2-1A6F-4F2C-AABD-44EE00047BE9Q50967527-EADCA3F5-815C-4248-ADA4-1BE70FCFF4D7Q53211347-9BE794C8-2081-4EE2-856D-866C013246E4Q53275350-60B1D0AB-A652-4BB5-85D4-C6B73CCDFBD7Q53724796-C4C2CD31-8E1D-4DF3-822F-BA82041D8C8DQ54493763-AC093E90-5CA3-43D5-8F4B-B4B5A9D962CB
P2860
Molecular targeted treatment and radiation therapy for rectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular targeted treatment and radiation therapy for rectal cancer.
@en
Molecular targeted treatment and radiation therapy for rectal cancer.
@nl
type
label
Molecular targeted treatment and radiation therapy for rectal cancer.
@en
Molecular targeted treatment and radiation therapy for rectal cancer.
@nl
prefLabel
Molecular targeted treatment and radiation therapy for rectal cancer.
@en
Molecular targeted treatment and radiation therapy for rectal cancer.
@nl
P2093
P2860
P1476
Molecular targeted treatment and radiation therapy for rectal cancer.
@en
P2093
Christian Weiss
Franz Rödel
Friederike Marquardt
Gianni Capalbo
P2860
P2888
P304
P356
10.1007/S00066-009-1936-5
P50
P577
2009-06-09T00:00:00Z